Cardiovascular disease

May 09, 2018 - 7:58 pm
LOS ANGELES (AP) — Federal prosecutors in California and Florida have sued to stop two companies from providing stem cell treatments, alleging the clinics marketed their procedures as remedies for ailments including cancer and heart disease without proof of safety and efficacy. The Justice...
Read More
April 19, 2018 - 3:31 am
GENEVA (AP) — Swiss pharmaceuticals company Novartis says net income jumped 12 percent in the first quarter, pointing to explosive growth in its heart-failure drug Entresto as its rollout continues, and powerful double-digit percentage growth for psoriasis drug Cosentyx. The Basel-based powerhouse...
Read More
FILE - In this Tuesday, July 23, 2002 file photo, a doctor holds the medication Zyban in Kansas City, Kan. According to industry-funded research mandated by U.S. and European regulators and released on Monday April 9, 2018, Chantix and Zyban, two heavily promoted smoking cessation drugs, are as safe for the heart as nicotine patches and dummy pills. (AP Photo/Ed Zurga)
April 09, 2018 - 12:35 pm
CHICAGO (AP) — Two popular stop-smoking drugs are as safe for the heart as nicotine patches and dummy pills, according to research requested by U.S. and European regulators. The results come from an extension of a big study of Chantix and Zyban that earlier found no increased risks for severe...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:40 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:28 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
March 10, 2018 - 9:17 am
ORLANDO, Fla. (AP) — Heart attack survivors who can't tolerate or get enough help from cholesterol-lowering drugs called statins soon may have an easier time getting insurers to pay for a newer medicine that works in a different way. The drug, Praluent (PRALL-yoo-ent), modestly cut the risk of...
Read More
Bauerle
January 21, 2018 - 9:00 pm
So, Bauerle and Bellavia returns to normal (is that possible?) Monday at 3 PM on News Radio 930 WBEN. I would like to thank Tim Wenger, Greg Ried and Entercom Corporate for their kindness and understanding following my December 3 heart attack and December 10 quadruple bypass. Also to my bro and...
Read More
Ri Tong Il, former North Korean deputy ambassador to the United Nations, speaks to journalist outside the North Korean embassy in Kuala Lumpur, Malaysia on Thursday, March 2, 2017. The North Korean envoy said a heart attack likely killed Kim Jong Nam, not VX nerve agent as a Malaysia autopsy showed, regarding the investigation into the assassination of Kim, the estranged half brother of North Korea's leader Kim Jong Un. Ri told reporters Thursday that the victim took medication for heart disease, diabetes and high blood pressure. (AP Photo/Vincent Thian)
March 02, 2017 - 8:49 pm
KUALA LUMPUR, Malaysia (AP) — Malaysia ramped up the pressure on Pyongyang on Friday, issuing a statement condemning the use of a banned toxic chemical weapon in the killing of the half brother of North Korea's leader. Malaysia has not directly accused North Korea of being behind the Feb. 13...
Read More
Ri Tong Il, former North Korean deputy ambassador to the United Nations, speaks to journalist outside the North Korean embassy in Kuala Lumpur, Malaysia on Thursday, March 2, 2017. The North Korean envoy said a heart attack likely killed Kim Jong Nam, not VX nerve agent as a Malaysia autopsy showed, regarding the investigation into the assassination of Kim, the estranged half brother of North Korea's leader Kim Jong Un. Ri told reporters Thursday that the victim took medication for heart disease, diabetes and high blood pressure. (AP Photo/Vincent Thian)
March 02, 2017 - 6:42 am
KUALA LUMPUR, Malaysia (AP) — A North Korean envoy rejected a Malaysian autopsy finding that VX nerve agent killed Kim Jong Nam, saying Thursday the man probably died of a heart attack because he suffered from heart disease, diabetes and high blood pressure. The death of Kim, the estranged half...
Read More
FILE - In this Feb. 9, 2012, file photo, first lady Michelle Obama and Bob Harper of "The Biggest Loser," right in blue shirt, do the Interlude dance during a Let's Move event with children from Iowa schools at the Wells Fargo Arena in Des Moines, Iowa. Harper tells TMZ he suffered a heart attack and was hospitalized for several days in February 2017. (AP Photo/Carolyn Kaster, File)
February 28, 2017 - 6:52 am
NEW YORK (AP) — "Biggest Loser" host Bob Harper says he's "feeling better" and "taking it easy" two weeks after suffering a heart attack. Harper made the statement on Facebook on Monday after news of the Feb. 12 attack became public. Harper told TMZ he collapsed at a New York City gym and a doctor...
Read More

Pages